DHBUF logo

Delivra Health Brands Inc. (DHBUF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Cotizando a $, Delivra Health Brands Inc. (DHBUF) es una empresa del sector Healthcare valorada en 0. Calificado con 45/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 45/100

Delivra Health Brands Inc. (DHBUF) Resumen de Asistencia Médica y Tuberías

CEOGord Davey
Empleados22
Sede CentralVancouver, CA
Año de la oferta pública inicial (OPI)2017

Delivra Health Brands Inc. operates in the healthcare sector, providing a diverse range of wellness products, including cannabis-based solutions, sleep aids, and pain relief creams, positioning itself as a unique player in the specialty drug manufacturing industry.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Delivra Health Brands Inc. presents a unique investment thesis driven by its focus on the cannabis and wellness market, which is projected to grow significantly in the coming years. The company's gross margin of 48.6% indicates strong profitability potential, despite a current negative profit margin of -3.1%. Delivra’s innovative product offerings, including liquid sleep shots and pain relief creams, are well-positioned to meet the increasing consumer demand for alternative health solutions. The ongoing trend towards natural and cannabis-based products is a key growth catalyst, as more consumers seek effective remedies for sleep and pain management. However, investors may want to evaluate the regulatory landscape and potential market volatility as risk factors. Overall, Delivra's commitment to quality and innovation, combined with its strategic market positioning, makes it a noteworthy player in the healthcare sector.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market Cap of $0.00B indicates early-stage growth potential in a burgeoning industry.
  • P/E ratio of -13.12 reflects current operational challenges but highlights potential for turnaround.
  • Gross margin of 48.6% exceeds industry averages, showcasing effective cost management.
  • Profit margin of -3.1% suggests ongoing investment in growth and product development.
  • Beta of 0.66 indicates lower volatility compared to the broader market, appealing to risk-averse investors.

Competidores y Pares

Fortalezas

  • Strong gross margin of 48.6% indicating effective cost management.
  • Innovative product offerings in the growing cannabis and wellness markets.
  • Established presence in regulated markets enhances credibility and trust.

Debilidades

  • Negative profit margin of -3.1% reflects operational challenges.
  • Small workforce may limit scalability and operational capacity.
  • Dependence on regulatory approval for product offerings.

Catalizadores

  • Upcoming: Expansion into new international markets as regulations evolve.
  • Ongoing: Development of new product lines targeting sleep and pain relief.
  • Ongoing: Increasing consumer demand for cannabis-based wellness products.

Riesgos

  • Potential: Regulatory changes impacting product availability.
  • Ongoing: Intense competition in the cannabis and wellness sectors.
  • Ongoing: Market volatility affecting consumer spending.

Oportunidades de crecimiento

  • Growth opportunity 1: The global cannabis market is expected to grow at a CAGR of 26.7% from 2021 to 2028, providing Delivra with significant opportunities to expand its product offerings in this sector. With increasing legalization and consumer acceptance, Delivra can leverage its existing cannabis products to capture a larger market share. The company’s innovative approach to cannabis-infused wellness products positions it favorably to meet the demands of health-conscious consumers.
  • Growth opportunity 2: The sleep aid market is projected to reach $101.9 billion by 2023, driven by rising awareness of sleep disorders and the need for effective solutions. Delivra's liquid sleep shots and sleep powder packets are well-positioned to capitalize on this trend. As more consumers seek natural alternatives to traditional sleep medications, Delivra's focus on quality and efficacy can help it gain traction in this lucrative market segment.
  • Growth opportunity 3: The pain relief market is anticipated to grow significantly, with a focus on non-opioid solutions. Delivra's pain relief creams align with this trend, offering consumers effective alternatives to traditional pain management methods. By expanding its product line and enhancing its marketing strategies, Delivra can tap into this growing demand for safe and effective pain relief options.
  • Growth opportunity 4: The increasing trend towards natural and organic products provides Delivra with an opportunity to enhance its brand image and attract health-conscious consumers. By emphasizing the natural ingredients in its product formulations, Delivra can differentiate itself from competitors and appeal to a broader audience. This strategic positioning can lead to increased sales and market share.
  • Growth opportunity 5: Expansion into international markets presents a significant growth opportunity for Delivra. As regulations around cannabis and wellness products continue to evolve globally, Delivra can explore new markets where demand for its products is rising. By establishing strategic partnerships and distribution channels, Delivra can enhance its global footprint and drive revenue growth.

Oportunidades

  • Expanding global cannabis market presents significant growth potential.
  • Increasing consumer demand for natural health solutions.
  • Potential for product line expansion in sleep and pain relief categories.

Amenazas

  • Regulatory changes could impact product availability and market access.
  • Intense competition in the cannabis and wellness sectors.
  • Market volatility may affect consumer spending on wellness products.

Ventajas competitivas

  • Delivra's focus on quality and compliance differentiates it from competitors.
  • The company's innovative product formulations cater to evolving consumer preferences.
  • Strong brand reputation in the cannabis wellness sector enhances customer loyalty.
  • Expertise in navigating regulatory landscapes provides a competitive advantage.

Acerca de DHBUF

Founded in Vancouver, Canada, Delivra Health Brands Inc. has established itself as a provider of lifestyle and wellness products in regulated markets globally. The company focuses on innovative solutions that cater to the needs of consumers and patients, particularly in the realm of cannabis and sleep enhancement. Delivra's product portfolio includes cannabis products, liquid sleep shots, sleep powder packets, and pain relief creams, which are designed to improve quality of life for its users. Over the years, Delivra has evolved to meet the increasing demand for alternative health solutions, leveraging its expertise in the cannabis sector to create effective and safe products. The company operates with a small team of 22 employees, emphasizing agility and innovation in its operations. By prioritizing quality and compliance, Delivra aims to build trust with its customers while navigating the complexities of the healthcare landscape. Its strategic focus on regulated markets allows it to capitalize on the growing acceptance of cannabis and wellness products, positioning itself favorably within the competitive landscape of drug manufacturers.

Qué hacen

  • Delivra Health Brands Inc. provides a range of lifestyle and wellness products.
  • The company specializes in cannabis-based solutions for health and wellness.
  • Delivra offers liquid sleep shots and sleep powder packets to aid sleep.
  • The product portfolio includes pain relief creams for effective pain management.
  • Delivra operates in regulated markets worldwide, ensuring compliance and quality.
  • The company focuses on innovation to meet consumer health needs.

Modelo de Negocio

  • Delivra generates revenue through the sale of wellness products, including cannabis items.
  • The company leverages its expertise in the cannabis sector to develop innovative solutions.
  • Delivra targets consumers and patients seeking alternative health products.
  • The company emphasizes quality and compliance to build trust with its customer base.

Contexto de la Industria

The drug manufacturing industry, particularly in the specialty and generic segments, is experiencing significant growth driven by increasing consumer demand for alternative health solutions. The global cannabis market is projected to reach $73.6 billion by 2027, fueled by rising acceptance and legalization in various regions. Delivra Health Brands Inc. operates within this dynamic landscape, focusing on wellness products that cater to evolving consumer preferences. The competitive landscape includes peers such as AYRWF, AYURF, CBIH, CLCFF, and CRRTF, each vying for market share in a rapidly expanding sector. Delivra's emphasis on quality and compliance positions it well against competitors, allowing it to capture a distinct market niche.

Clientes Clave

  • Health-conscious consumers seeking natural wellness solutions.
  • Patients looking for effective sleep aids and pain relief options.
  • Retailers and distributors in regulated markets for cannabis products.
  • Individuals interested in alternative health remedies.
Confianza de la IA: 65% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Delivra Health Brands Inc. (DHBUF): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para DHBUF.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para DHBUF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para DHBUF.

MoonshotScore

45/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de DHBUF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Gord Davey

CEO

Gord Davey has extensive experience in the healthcare and wellness sectors, having held various leadership roles throughout his career. His background includes a strong focus on product development and market strategy, enabling him to drive growth and innovation at Delivra Health Brands Inc. Gord is known for his commitment to quality and compliance, which are critical in the regulated markets in which the company operates.

Historial: Under Gord's leadership, Delivra has successfully launched several innovative wellness products, establishing a strong brand presence in the cannabis sector. His strategic decisions have positioned the company for future growth, particularly in expanding its product offerings and entering new markets.

Información del mercado OTC de DHBUF

The OTC Other tier includes companies that do not meet the higher financial or regulatory standards of the NYSE or NASDAQ. Companies in this tier may have less stringent reporting requirements, leading to lower visibility and liquidity compared to those on major exchanges.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Trading volume for OTC stocks can be lower, leading to wider bid-ask spreads and potential challenges in executing trades. Investors may experience difficulty in buying or selling shares quickly at desired prices.
Factores de riesgo OTC:
  • Lack of transparency in financial reporting compared to major exchanges.
  • Potential for lower liquidity, impacting trading efficiency.
  • Regulatory risks associated with operating in the cannabis sector.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and disclosures.
  • Assess the regulatory landscape affecting cannabis products.
  • Evaluate market trends and consumer demand for wellness products.
  • Research competitive positioning within the cannabis and wellness sectors.
  • Review management's track record and strategic vision.
Señales de legitimidad:
  • Established presence in regulated markets enhances credibility.
  • Innovative product offerings demonstrate commitment to quality.
  • Experienced leadership team with a strong background in healthcare.

Acciones de Delivra Health Brands Inc.: Preguntas Clave Respondidas

¿Cuáles son los factores clave para evaluar DHBUF?

Delivra Health Brands Inc. (DHBUF) actualmente tiene una puntuación IA de 45/100, indicando puntuación baja. Fortaleza clave: Strong gross margin of 48.6% indicating effective cost management.. Riesgo principal a monitorear: Potential: Regulatory changes impacting product availability.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de DHBUF?

DHBUF actualmente puntúa 45/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de DHBUF?

Los precios de DHBUF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre DHBUF?

La cobertura de analistas para DHBUF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en DHBUF?

Las categorías de riesgo para DHBUF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Regulatory changes impacting product availability.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de DHBUF?

La relación P/E para DHBUF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está DHBUF sobrevalorada o infravalorada?

Determinar si Delivra Health Brands Inc. (DHBUF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de DHBUF?

Delivra Health Brands Inc. (DHBUF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Financial data may be limited due to OTC classification and disclosure status.
Fuentes de datos

Popular Stocks